PPCM
UTHR icon

Pillar Pacific Capital Management’s United Therapeutics UTHR Stock Holding History

Pillar Pacific Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$589K Sell
3,525
-350
-9% -$58.4K 0.05% 183
2020
Q4 		$589K Hold
3,875
– – 0.05% 189
2020
Q3 		$391K Hold
3,875
– – 0.04% 214
2020
Q2 		$469K Hold
3,875
– – 0.05% 184
2020
Q1 		$367K Hold
3,875
– – 0.05% 189
2019
Q4 		$341K Hold
3,875
– – 0.04% 224
2019
Q3 		$309K Sell
3,875
-150
-4% -$12.1K 0.03% 224
2019
Q2 		$314K Hold
4,025
– – 0.04% 232
2019
Q1 		$472K Sell
4,025
-100
-2% -$11.7K 0.05% 174
2018
Q4 		$449K Hold
4,125
– – 0.06% 171
2018
Q3 		$527K Hold
4,125
– – 0.06% 180
2018
Q2 		$467K Buy
4,125
+100
+2% +$11K 0.05% 187
2018
Q1 		$452K Sell
4,025
-150
-4% -$19.1K 0.05% 182
2017
Q4 		$618K Buy
4,175
+40
+1% +$5.08K 0.08% 160
2017
Q3 		$485K Sell
4,135
-200
-5% -$25.5K 0.06% 179
2017
Q2 		$562K Sell
4,335
-190
-4% -$23.7K 0.08% 163
2017
Q1 		$612K Hold
4,525
– – 0.09% 152
2016
Q4 		$649K Sell
4,525
-400
-8% -$51.1K 0.1% 135
2016
Q3 		$581K Hold
4,925
– – 0.09% 141
2016
Q2 		$522K Hold
4,925
– – 0.09% 144
2016
Q1 		$548K Hold
4,925
– – 0.1% 143
2015
Q4 		$771K Hold
4,925
– – 0.14% 131
2015
Q3 		$646K Buy
4,925
+200
+4% +$32.1K 0.12% 131
2015
Q2 		$822K Hold
4,725
– – 0.14% 125
2015
Q1 		$815K Sell
4,725
-250
-5% -$38.1K 0.14% 125
2014
Q4 		$644K Sell
4,975
-500
-9% -$64.4K 0.12% 129
2014
Q3 		$704K Sell
5,475
-150
-3% -$15.5K 0.13% 135
2014
Q2 		$498K Hold
5,625
– – 0.09% 151
2014
Q1 		$529K Hold
5,625
– – 0.11% 148
2013
Q4 		$636K Hold
5,625
– – 0.13% 140
2013
Q3 		$443K Hold
5,625
– – 0.1% 155
2013
Q2 		$370K Buy
+5,625
New +$362K 0.09% 174

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Pillar Pacific Capital Management's UTHR Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its United Therapeutics (UTHR) stake by 9% in Q1 2021, selling an estimated $58.4K and leaving 3,525 shares worth $589K. The position accounts for 0.05% of the portfolio, ranked #183.

Pillar Pacific Capital Management first reported a position in UTHR in Q2 2013 and has held it in 32 quarters since. The position peaked at $822K in Q2 2015. 391 funds tracked by Wall St. Rank hold UTHR as of Q1 2021.

  • Pillar Pacific Capital Management held 3,525 shares of United Therapeutics worth $589K as of Q1 2021.
  • Pillar Pacific Capital Management sold 350 United Therapeutics shares in Q1 2021, an estimated $58.4K.
  • United Therapeutics made up 0.05% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #183 holding.
  • Pillar Pacific Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 32 quarters since.
  • Pillar Pacific Capital Management's United Therapeutics position peaked at $822K in Q2 2015.
  • 391 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.